Fund profile
MGV
San Francisco, USA
Not leading
About
Maschmeyer Group Ventures (MGV) is a San Francisco-based early-stage venture capital firm founded in 2017 by Marc Schroeder (Founding and Managing Partner) and Carsten Maschmeyer (Founding Partner and Chairman), one of Germany's most prominent entrepreneurs and investors. The firm positions itself as a top-quartile SaaS fund focused on exceptional American technology companies, with offices in San Francisco, Munich, Berlin, and Hannover and a team of seven including three partners. MGV's primary geographic focus spans North America, Latin America, and Israel. The firm invests up to $750,000 at the Seed and Series A stages alongside a lead investor, concentrating on SaaS, AI and machine learning, fintech, proptech, e-commerce, and data analytics. Across 63 total investments, the portfolio has generated 6 exits including Telivy (January 2025), Modern Health (2024), and Observe.AI (2022). Recent investments include Woz (business productivity software, October 2025) and Cascade Space. Other notable portfolio companies include Runa HR, Glide (no-code application builder), and Tomorrow Ideas. MGV's defining value-add is hands-on go-to-market support: the team actively helps founders build scalable sales organizations, open enterprise customer channels, and develop repeatable revenue models. The firm's founder-first evaluation approach prioritizes drive, humility, and leadership capacity over strict traction or revenue thresholds, reflecting the belief that the best SaaS outcomes are built by exceptional people as much as exceptional products. Maschmeyer's European network and Schroeder's operational background give portfolio companies a transatlantic perspective during the critical early scaling phase.
Details
Highlights
$1.7M
Historical average check
$750k
Historical max check
October 2025
Last investment date
63
Investments
Fintech & Financial services
AI & Deep Tech
Software & Apps
Security & Privacy
Data & Analytics
Hardware. Robotics & IoT
Healthtech & Wellness
Pharma
Other
Showing 0 lists
Contacts
Lists that include this fund